the serotonin 5-ht1a-receptor agonist, 8-oh-dpat...
TRANSCRIPT
JPET #108944
1
The Serotonin 5-HT1A-receptor agonist, 8-OH-DPAT, stimulates
sympathetic-dependent increases in venous tone during hypovolemic shock
Ruslan Tiniakov
And
Karie E.Scrogin
Department of Pharmacology and Experimental Therapeutics
Loyola University Chicago, Stritch School of Medicine
JPET Fast Forward. Published on August 2, 2006 as DOI:10.1124/jpet.106.108944
Copyright 2006 by the American Society for Pharmacology and Experimental Therapeutics.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
2
Running Title: 8-OH-DPAT raises venous tone in hypovolemic shock
Corresponding Author: Karie Scrogin, Ph.D., Department of Pharmacology, 2160 S.
First Ave. Maywood, IL 60153, Tel: 708-216-5652; FAX:
708-216-6596 [email protected]
text pages: 16
tables: 1
Figures: 8
References: 28
Word Count: Abstract: 243
Introduction: 450
Discussion: 1,500
Abbreviations:
8-OH-DPAT (+) 8-hydroxy-2-(di-n-propylamino)-tetralin MCFP Mean Circulatory Filling Pressure 5-HT 5-hydroxytryptaphan HR Heart Rate VPP Venous Plateau Pressure FAP Final Arterial Pressure ANOVA Analysis of Variance CVP Central Venous Pressure MAP Mean Arterial Pressure
Recommended Section Assignment: Cardiovascular
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
3
Abstract
Adjuvant treatment of hypovolemic shock with vasoconstrictors is controversial
due to their propensity to raise arterial resistance and exacerbate ischemia. A more
advantageous therapeutic approach would utilize agents that also promote
venoconstriction to augment perfusion pressure through increased venous return. Recent
studies indicate that 5-HT1A-receptor agonists increase blood pressure by stimulating
sympathetic drive when administered after acute hypotensive hemorrhage. Given that
venous tone is highly dependent upon sympathetic activation of α2-adrenerigc receptors,
we hypothesized that the 5-HT1A-receptor agonist, 8-OH-DPAT, would increase venous
tone in rats subject to hypovolemic shock through sympathetic activation of α2-
adrenergic receptors. Systemic administration of 8-OH-DPAT produced a sustained rise
in blood pressure (+44 ± 3 mm Hg 35 min after injection, P<0.01 vs. saline) and mean
circulatory filling pressure (+4.2 ± 0.7 mm Hg, P<0.01 vs. saline) in conscious rats
subjected to hypovolemic shock. An equipressor infusion of epinephrine failed to
influence mean circulatory filling pressure (MCFP). Ganglionic blockade, α1- or
peripheral α2-adrenergic receptor blockade prevented the rise in MCFP observed with 8-
OH-DPAT, but only α1-adrenergic receptor blockade diminished the pressor effect of the
drug (P<0.01). 8-OH-DPAT raises blood pressure in rats in hypovolemic shock through
both direct vascular activation- and sympathetic activation of α1-adrenergic receptors.
The sympathoexcitatory effect of 8-OH-DPAT contributes to elevated venous tone
through concurrent activation of both α1- and α2-adrenergic receptors. The data suggest
that 5-HT1A receptor agonists may provide an advantageous alternative to currently
therapeutic interventions used to raise perfusion pressure in hypovolemic shock.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
4
Introduction
Progressive and severe blood loss elicits a complex series of autonomic responses
that help to maintain or restore arterial blood pressure. During the initial phase of blood
loss, arterial baroreflex-mediated increases in sympathetic drive help to maintain arterial
pressure. If blood loss continues, these compensatory responses suddenly abate resulting
in a syncopal-like episode characterized by low sympathetic activity and bradycardia
(Schadt and Ludbrook, 1991). It is speculated that this latter phase may provide an
adaptive means to increase cardiac filling and to help maintain cerebral perfusion (Oberg
and Thoren, 1970;van Lieshout, et al., 2003). If hypotension persists, arterial baroreflex
activity slowly recovers and progressive increases in sympathetic drive and tachycardia
develop. The clinical features of this third phase of hemorrhage are commonly observed
in patients who arrive in the emergency room after traumatic blood loss. Interventions at
this stage must be rapid in order to prevent patients from progressing to a fourth, mostly
irreversible stage of shock characterized by insensitivity to vasoconstrictors and high
capillary permeability, both of which contribute to further maldistribution of blood
volume and eventually death.
Rapid re-infusion of volume is a universally accepted treatment of hypovolemic
shock. However, the type of resuscitation fluid used, as well as the amount and rate of
re-infusion remain controversial. Also controversial is the choice of vasoconstrictor
adjuvants used to help raise perfusion pressure. Epinephrine and other sympathomimetic
agents are commonly given to support blood pressure during severe hypotensive shock
when volume alone is insufficient to maintain pressure. However, catecholamine use is
fraught with complications related to excessive vasoconstriction and exacerbation of
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
5
ischemia as well as generation of arrhythmias (Meier-Hellmann, et al., 1997). More
recent evidence indicate that vasopressin and vasopressin analogues may be good
alternatives to maintain arterial blood pressure in various types of shock (Kam, et al.,
2004). While vasopressin is a highly potent arterial vasoconstrictor, it has virtually no
vasoconstrictor effects on the venous vasculature (Warner, 1990). Theoretically, pressor
agents that promote venous return and cardiac filling would provide a more favorable
hemodynamic response than agents that act primarily by increasing arterial resistance.
However, little is known about the venoconstrictor effects of pressor agents in
hypovolemic shock.
We have shown that the 5-HT1A-receptor agonists, (+)8-hydroxy-2-(di-n-
propylamino)-tetralin (8-OH-DPAT), produces a potent sympathoexcitatory response in
conscious rats when administered during the syncopal phase of blood loss (Osei-Owusu
and Scrogin, 2004b;Scrogin, 2003). Preliminary data also indicate that 8-OH-DPAT is
an effective pressor agent when administered to rats in hypovolemic shock (Henze, et al.,
2005). Venous tone is regulated largely by sympathetic drive (Pang, 2001). Therefore,
we tested the hypothesis that 8-OH-DPAT increases arterial pressure during hypovolemic
shock, in part, by stimulating sympathetic-mediated increases in venous tone through
adrenergic receptor activation.
Methods
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
6
Animals
Male Sprague-Dawley rats weighing 310-360 gm (Harlan, Indianapolis, IN) were
maintained in the institutional animal facility under standard conditions (22±2°C ambient
temperature, 12:12 h light/dark cycle) with water and food provided ad libitum. All
experiments were conducted in accordance with the Guide for the Care and Use of
Laboratory Animals as adopted and promulgated by the National Institutes of Health.
Surgery
Four days prior to experiments, rats were anesthetized with sodium pentobarbital
(60 mg/kg, i.p, Sigma) and instrumented with bilateral femoral arterial- and unilateral
femoral venous polyethylene catheters for measurement of arterial pressure, arterial
blood withdrawal and drug injections respectively. Silastic tubing (OD 0.037 in) was
inserted into the thoracic vena cava via the femoral vein for measurement of the central
venous pressure. A saline-filled inflatable balloon-tipped catheter (Vesta, Inc., Franklin,
WI) was inserted into the right atrium via the jugular vein to allow brief cessation of
circulation for measurement of mean circulatory filling pressure (MCFP), an indirect
measure of venous tone. All catheters were tunneled under the skin to exit at the nape of
a neck.
Experimental Protocols
Hemorrhage procedure
On the day of the experiment, animals were connected to the recording
instrumentation while resting unrestrained in their home cage. Two measurements of
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
7
baseline MCFP were taken 20 and 10 minutes prior to initiation of hemorrhage according
to methods developed by Yamamoto et al. (Yamamoto, et al., 1980). Hemorrhage was
initiated using a modified Wigger’s model. Blood was withdrawn at a rate of 3.2
ml/kg/min for 6 minutes, after which the rate was reduced to 0.53 ml/kg/min for an
additional 4 minutes. Over the following 15 min, small amounts of blood (0.1-0.25 ml)
were withdrawn or infused manually in order to maintain MAP at 50 mm Hg. All blood
volume manipulations were terminated 25 min after initiation of hemorrhage, after which
blood pressure was allowed to fluctuate. MCFP measurements were performed 20, 30,
40, 50, and 60 min after initiation of blood withdrawal.
Study 1
Animals were randomly assigned to one of 3 experimental groups all of which
were given saline (150 µl, iv) 15 min after the initiation of blood withdrawal to control
for volume of drug injections used in later protocols. Ten minutes later, immediately
after the termination of blood withdrawal, animals were given 8-OH-DPAT (9.85
µg/kg/150 µl, iv, Research Biochemicals International) or saline. A third group received
a variable infusion of epinephrine (2.5-1.0 µg/kg, Hospira, Inc), to match the blood
pressure response of 8-OH-DPAT-treated rats. Arterial blood sampled 10 min after
initiation of blood withdrawal (end of fixed-rate withdrawal) and 2 min after the last
MCFP measurement were used for determination of hematocrit and total plasma protein
concentration to assess the extent of hemodilution.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
8
Study 2
Rats were subject to the hemorrhage protocol described above, but were given the
autonomic ganglionic blocker, hexamethonium chloride (30 mg/kg, iv, Sigma), 15 min
after the initiation of hemorrhage, followed 10 min later by either saline or 8-OH-DPAT
(9.85/kg/150 µl, iv).
Study 3
Rats were treated as in study 2 but were pretreated with the α1-adrenergic receptor
blocker, prazosin (25 µg/kg, iv, Sigma), rather than hexamethonium.
Study 4
Rats were treated as in study 2 except they were pre-treated with peripherally-
acting α2-adrenergic receptor blocker, L-659,066 (100 µg/kg, iv; (2R-trans)-N-(2-
(1,3,4,7,12 b-hexahydro-2’-oxo-spiro(2 H-benzofuro(2,3-a)quinolizine- 2,4’-
imidazolidin) –3’-yl)ethyl) methanesulphonamide monohydrochloride; Merck), rather
than hexamethonium.
Data acquisition and analysis
During all experiments, arterial and central venous pressures (CVP) were
recorded continuously on a Macintosh G4 PowerBook computer using PowerLab data
acquisition software (Chart v.5.2.1, ADInstruments, Grand Junction, CO). Heart rate was
calculated on line using peak-to-peak detection of the arterial pulse pressure wave.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
9
Mean arterial pressure, HR and CVP were averaged within subject over 20 sec segments
and averaged within groups at 5 min intervals.
Mean circulatory filling pressure (MCFP) was determined by initiating circulatory
arrest by brief (~5sec) inflation of the balloon catheter. During balloon inflation, central
venous pressure increased to a plateau level (VPP), while MAP decreased to a nadir,
referred to as final arterial pressure (FAP). Mean circulatory filling pressure was
calculated as VPP + 1/60(FAP – VPP). Total blood volume withdrawn during the
course of hemorrhage was determined gravimetrically at the end of the hemorrhage
period.
Two and 3-way ANOVAs with repeated measures were used to determine effects
of autonomic manipulations and 8-OH-DPAT or epinephrine treatment over time (from
25 through 60 min after start of hemorrhage) on hemodynamic parameters where
appropriate. Separate one and 2-way ANOVAs were used to assess effects of pressor
agents on MCFP or the effects of hexamethonium-, prazosin- or L-659,066-treatment on
MCFP responses to 8-OH-DPAT over time (from 20 through 60 min after start of
hemorrhage). Significant main effects and interactions were followed up with
Tukey/Kramer post-hoc tests. Total blood loss was pooled across pre-treatment groups.
Total blood loss as well as change in hematocrit and plasma protein were analyzed by 2-
way ANOVA followed by Tukey/Kramer post-hoc tests. Change in plasma protein and
hematocrit of the two groups treated with L-659,066 were excluded from the ANOVA
due to excessive variability.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
10
Results
Statistical analyses showed no differences in hemodynamic responses to
hemorrhage prior to drug treatment in the any of the groups. Thus, BP, HR and CVP data
obtained prior to drug administration were pooled across groups prior to drug
administration for clarity of presentation and to assess the hemodynamic profile during
the initial blood withdrawal period.
Hemodynamic effect of 8-OH-DPAT in circulatory shock
The initial blood withdrawal (22.4 ml/kg) over the first 10 min of hemorrhage
caused a precipitous drop in MAP (-70.4 ± 3.5 mmHg), HR (-138 ± 23 bpm) and CVP (-
1.5 ± 0.5 mmHg). An additional 12.2 ± 1.0 ml/kg of blood was withdrawn over the
following 15 min in order to maintain MAP at 50 mmHg. Heart rate reached a nadir 10
min after initiation of blood withdrawal, but then began to rise steadily and stabilized
near baseline by the end of blood withdrawal. Changes in CVP paralleled changes in
MAP (Figure 1).
Following termination of hemorrhage, 8-OH-DPAT administration caused a rapid
rise in MAP that persisted throughout the 35 min post-hemorrhage recording period.
Heart rate and CVP were not affected by 8-OH-DPAT. Continuous infusion of
epinephrine, titrated to match the pressor effect of 8-OH-DPAT caused a distinct
tachycardia during the early part of the infusion (Figure 1).
Balloon inflation prior to hemorrhage caused a large rise in CVP. In subsequent
tests after blood loss the rise in CVP was markedly attenuated and remained low
throughout the post hemorrhage period in saline-treated rats. The rise in CVP during
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
11
balloon inflation was exaggerated in hemorrhaged rats given 8-OH-DPAT (data not
shown). This resulted in a significant elevation of MCFP that lasted throughout the
recovery period. Epinephrine infusion had no effect on MCFP (Figure 2).
Effect of Autonomic Blockade on hemodynamic responses to 8-OH-DPAT
Ganglionic blockade caused an immediate drop in pressure below the target MAP
of 50 mmHg (data not shown). This was quickly rectified by re-infusion of a small
amount of shed blood. As a result, the total blood withdrawal needed to sustain
hypotension was reduced in rats given hexamethonium (Table 1). Ganglionic blockade
had a slight, but non-significant tachycardic effect and did not influence CVP (data not
shown).
Ganglionic blockade attenuated recovery of blood pressure following termination
of hemorrhage. However, the immediate pressor response to 8-OH-DPAT was similar in
intact and ganglionic-blocked rats when compared to their respective control groups
(Figure 3, compare light and dark gray shaded areas). With time, the pressor response
diminished in ganglionic-blocked animals (darker gray), but grew larger in intact animals
(light gray). An overall ANOVA revealed a significant interaction between Ganglionic
Blockade, 8-OH-DPAT Treatment and Time (P<0.01). Subsequent 2-way ANOVAs
performed at each time point showed significant interactions between Ganglionic
Blockade and 8-OH-DPAT 50 and 55 min after the start of hemorrhage due to the waning
pressor effect of 8-OH-DPAT after ganglionic blockade and the persistent pressor effect
in intact animals. Heart rate and CVP were not significantly affected by 8-OH-DPAT in
either intact- or ganglionic-blocked rats (data not shown).
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
12
MCFP is directly affected by both blood volume and venous tone (Guyton, et al.,
1954). Since the total volume of blood withdrawn differed among rats given various pre-
treatments (i.e, hexamethonium, prazosin, L-659,066 or saline), MCFP was only
compared between groups subjected to similar degrees of blood withdrawal, e.g., in study
2, only 8-OH-DPAT- and saline-treated rats subjected to ganglionic blockade were
compared to one another, while animals with intact autonomic responses were compared
in a separate analysis. In contrast to intact rats, 8-OH-DPAT did not increase MCFP after
ganglionic blockade (Figure 4).
Effect of Prazosin on 8-OH-DPAT-mediated hemodynamics
Blockade of peripheral α1-adrenergic receptors exacerbated the hemorrhage-
induced hypotension resulting in less blood withdrawal over the course of hemorrhage
(Table 1). Prazosin also attenuated recovery of blood pressure following termination of
hemorrhage and completely blocked the pressor effect of 8-OH-DPAT (Figure 5).
Prazosin had no effect on either HR or CVP (data not shown), but blocked the ability of
8-OH-DPAT to increase MCFP (Figure 6).
Effect of L-659,066 on 8-OH-DPAT-mediated hemodynamics
Blockade of peripheral α2-adrenergic receptors did not alter blood pressure prior
to saline or 8-O-DPAT administration. Consequently, total blood loss did not differ
between rats pre-treated with the α2-adrenergic receptor antagonist and those pre-treated
with saline (Table 1). However, α2-adrenergic receptor blockade did attenuate the
recovery of blood pressure following termination of blood withdrawal and tended to
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
13
accelerate decompensation in a subset of animals leading to the increased blood pressure
variability observed at the end of the recording period. The magnitude of the initial
pressor response to 8-OH-DPAT was not affected by α2-receptor blockade. Though the
blood pressure profile observed after L-659,066 clearly resembled that observed after
hexamethonium, there was no significant interaction between L-659,066 and 8-OH-
DPAT treatment either as a whole or over time. L-659,066 raised HR and CVP
immediately after injection, but did not influence the HR or CVP response to 8-OH-
DPAT (Figure 7).
L-659,066 pre-treatment blocked the effect of 8-OH-DPAT on MCFP (Figure 8).
L-659,066 itself appeared to lower MCFP compared to control animals despite a similar
volume of blood withdrawal during hemorrhage (compare Figures 2 and 8). However,
hematocrit and plasma protein changes were highly variable in animals treated with L-
659,066. Therefore, MCFP of saline- and L-659,066-treated rats was not directly
compared.
Discussion
In the current study, 8-OH-DPAT elicited a significant pressor response when
administered during hypovolemic shock. The pressor effect was mediated by a
combination of direct- and sympathetic-dependent activation of α1-adrenergic receptors.
8-OH-DPAT produced a similar initial pressor effect in the absence of ganglionic
blockade suggesting that the direct vascular effect of 8-OH-DPAT predominated
immediately after drug treatment. The pressor effect waned after 20-25 min in animals
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
14
subjected to ganglionic blockade, but persisted in intact animals, indicating that the
sympathetic component of the pressor response elicited a lasting hemodynamic effect.
Sympathetic-dependent activation of α1-adrenergic receptors mediated a
significant amount of the compensatory vasoconstriction that developed following
termination of blood withdrawal in control animals. This was evidenced by the lower
blood pressure observed in prazosin-treated rats following termination of blood
withdrawal despite their having had significantly less blood withdrawn than control
animals during hemorrhage. Vascular α2-adrenergic receptors also contributed to
compensation during recovery. However, the effect was not immediate as the α2-
adrenergic antagonist, L-695,099, did not reduce the volume of blood withdrawal
necessary to maintain pressure during active hemorrhage. After hemorrhage termination,
blood pressure of α2 antagonist-treated rats began to fall towards the end of the recording
period. In fact, several animals pre-treated with the α2-antagonist alone tended to
develop what appeared to be the beginning of irreversible decompensation prior to the
end of the recording period. 8-OH-DPAT protected against this effect suggesting that
sympathetic activation of α1-receptors may compensate for lack of α2 -receptor activation
to maintain blood pressure.
8-OH-DPAT markedly elevated MCFP through an autonomic-dependent
mechanism. MCFP is determined by total blood volume and overall vascular
compliance. Thus, MCFP is primarily dependent on volume and venous tone since
venous compliance is so much larger than arterial compliance (Guyton, et al., 1954).
Thus, 8-OH-DPAT mediated its effects on MCFP in hemorrhaged animals either by
increasing vascular blood volume, venous tone or both. Neither the volume of blood
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
15
withdrawn, nor the hemorrhage-induced change in hematocrit differed between 8-OH-
DPAT- and saline-treated control groups suggesting that differences in capillary refilling
contributed little to the difference in MCFP. However, it cannot be ruled out that the
assessment of hemodilution differences was confounded by a sympathetic-mediated
increase in erythrocyte release by splenic contraction in 8-OH-DPAT-treated animals
(Kuwahira, et al., 1999). However, plasma protein declined to the same degree in
animals treated with 8-OH-DPAT and saline, favoring the view that increases in MCFP
were primarily mediated by increased venous tone.
The rise in MCFP was prevented by either α1- or α2-receptor blockade suggesting
that both receptor subtypes must be available in order for 8-OH-DPAT to increase venous
tone during hypovolemic shock. In accord, previous studies have shown that treatment
with either prazosin or rauwolscine produces a dose-dependent decrease in MCFP in
euvolemic conscious rats, but only during reflex sympathetic activation (D'Oyley and
Pang, 1990). Prazosin was also found to reduce MCFP in an anesthetized, open chest
dog preparation, but only during infusion of norepinephrine (Ito and Hirakawa, 1984).
Selective α1-adrenergic agonists produce little increase in MCFP when infused into intact
rats, while norepinephrine produces a potent, dose-dependent increase in MCFP (Pang
and Tabrizchi, 1986). Studies in isolated mesenteric veins confirm that activation of α1-
adrenergic receptors may be necessary to observe a venoconstrictor effect of α2-
adrenergic receptors in some vascular beds. Specifically, clonidine and other α2-
adrenergic agonists alone do not produce mesenteric venoconstriction, but yohimbine,
idazoxan or rauwolscine inhibit venoconstriction caused by norepinephrine (Greg Fink,
Ph.D., unpublished data, 2006). Taken together the data suggest that α1- and α2-
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
16
adrenergic receptor populations interact with one another to mediate sympathetic-
dependent increases in venous tone.
Surprisingly, epinephrine did not affect MCFP despite its high affinity and agonist
activity at both α1- and α2-adrenergic receptor subtypes. To our knowledge, the effect of
epinephrine on MCFP has not previously been studied in mammals. Selective β-receptor
agonists tend to increase MCFP in intact rats, but produce a consistent decrease in MCFP
when administered after blockade of sympathetic reflexes (Abdelrahman and Pang,
1990). Thus, the β-adrenergic properties of epinephrine may have antagonized its α-
adrenergic mediated venoconstrictor effect. Alternatively, the venoconstrictor effect of
epinephrine may have been masked by a concomitant loss of circulating blood volume
due to increased capillary filtration. Though not significant, the fall in hematocrit tended
to be larger with epinephrine infusion arguing against a greater loss of intravascular
volume in this group.
Presumably, a peripherally acting agent with both α1 and α2 agonists activity, but
little β2 activity such as norepinephrine would significantly increase venous tone during
hemorrhage. As described above norepinephrine has a potent effect on MCFP in intact
animals. To our knowledge, no one has yet determined the effect of norepinephrine on
MCFP in hemorrhage. Such studies are problematic because of norepinephrine’s
propensity to exacerbate ischemia during hypovolemia. There were no outward signs of
exacerbated ischemia in animals treated with 8-OH-DPAT. In accord, preliminary
evidence suggests that the 8-OH-DPAT does not exacerbate ischemic end-organ injury as
assessed by hemorrage-induced neutrophil activation in lung, kidney or gut (Osei-Owusu
and Scrogin, 2004a).
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
17
An increase in venous tone should result in an elevation in venous return and a
rise in blood pressure if right atrial pressure is maintained. Surprisingly, neither
ganglionic blockade nor α2-receptor blockade had any apparent effect on the initial
pressor response to 8-OH-DPAT despite their ability to block the 8-OH-DPAT-mediated
rise in MCFP. However, it could be argued that the direct arterial vasoconstrictor effect
of 8-OH-DPAT was exaggerated after ganglionic blockade due to the greater availability
of adrenergic receptors. Pressor responses to norepinephrine are exaggerated in
euvolemic animals after ganglionic blockade (Del Basso, et al., 1983;Rowe, et al., 1979).
The pressor response to 8-OH-DPAT-mediated sympathetic activation was also likely
exaggerated during α2-receptor blockade due to lack of α2-adrenergic autoreceptor
inhibition of catecholamine release. This view is supported by the greater HR rise
observed during blood withdrawal in animals treated with L-659,066. Thus, we suspect
that the rise in MCFP elicited by 8-OH-DPAT does indeed contribute to increased venous
return via its sympathoexcitatory action.
The similarity in the blood pressure profiles of animals treated with 8-OH-DPAT
following ganglionic blockade and α2-adrenergic antagonist administration suggests that
the late pressor effect of 8-OH-DPAT was mediated largely by sympathetic activation of
α2-adrenergic receptors. Animals subjected to ganglionic blockade, however, did not
show the late decompensatory response seen after selective α2-adrenergic blockade.
However, it should be recognized that rats treated with the ganglionic blocker were
subjected to significantly less blood withdrawal than those treated with the α2-recpetor
antagonist.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
18
It is possible that MCFP was increased by mobilization of blood stores following
8-OH-DPAT-medated increases in sympathetic drive. Sympathetic activation produces
a prolonged, slow contraction of the spleen in rats (Kuwahira, et al., 1999). The rat
spleen is innervated by sympathetic nerves and expresses a high density of α2-adrenergic
receptors (Handy, et al., 1993). Moreover, α2-adrenergic receptor antagonists interfere
with hypoxia induced increases in hematocrit proposed to result from splenic contraction
in the rat (Kuwahira, et al., 1999). It has been proposed that the rat spleen, like that of
the human, contributes to intravascular blood volume regulation primarily through
diversion of cell free filtrate to the lymphatic system, most likely through reflex
sympathoinhibition stimulated by cardiopulmonary stretch (Kaufman and Deng, 1993).
8-OH-DPAT could exaggerate sympathetic activation during hypovolemia thus
attenuating splenic filtration. The lack of difference in hematocrit fall after 8-OH-DPAT
would argue against this view. Nevertheless, the delayed decompensatory effect of the
α2-adrenergic receptor antagonist observed in the current study may reflect blockade of a
relatively slow contribution of the spleen or other splanchnic organs to venous return.
The slow rise in heart rate observed over the duration of active hemorrhage
suggests that a parallel increase in sympathetic drive also likely occurs. Our preliminary
studies indicate that renal sympathetic activity rises in parallel with heart rate in this
model of hypovolemic shock (data not shown). It is tempting to speculate that 8-OH-
DPAT accelerates the sympathetic-mediated fluid redistribution that normally occurs
during compensation. The rapid rise in sympathetic activity appears to provide a superior
hemodynamic response compared to that elicited by epinephrine infusion. Like 8-OH-
DPAT, hypertonic saline resuscitation has also been found to increase sympathetic
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
19
activation and promote favorable hemodynamic responses compared to vasoconstrictor
infusion (Seki, et al., 1997).
The data herein indicate that 5-HT1A agonist may provide an advantageous
alternative to direct vasoconstrictors in the treatment of hypovolemic shock, in part,
because it mobilizes existing blood stores. An additional advantage of 8-OH-DPAT is its
relatively long half-life (~20 min), making it amenable to single dosing during emergent
resuscitation outside of the hospital. 5-HT1A-receptor agonists also produce mild
hypothermic effects and stimulate the hypothalamo-pituitary adrenal axis, and thus
glucocorticoid release, suggesting they may combate ischemia reperfusion injury (Cleare,
et al., 1998;Shiah, et al., 1998). 5-HT1A-receptor agonists are also neuroprotective during
cerebral ischemia, presumably due to their ability to inhibit glutamatergic neurotoxicity
(Bielenberg and Burkhardt, 1990;Semkova, et al., 1998). These characteristics, together
with the data provided here suggest that 5-HT1A-receptor agonists may provide a
beneficial alternative to currently used vasoconstrictors to raise pressure during
hypovolemic shock.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
20
Acknowledgements
L-659,066 was kindly provided by Merck & Co., Inc.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
21
References
Abdelrahman A and Pang CC (1990) Differential venous effects of isoprenaline in
conscious rats. Eur J Pharmacol 190:321-327.
Bielenberg GW and Burkhardt M (1990) 5-hydroxytryptamine1A agonists. A new
therapeutic principle for stroke treatment. Stroke 21:IV161-IV163.
Cleare AJ, Forsling M and Bond AJ (1998) Neuroendocrine and hypothermic effects of
5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study.
Int Clin Psychopharmacol 13:23-32.
D'Oyley HM and Pang CC (1990) Effects of alpha 1- and alpha 2-adrenoceptor
antagonists on venous tone in conscious rats. Eur J Pharmacol 182:283-290.
Del Basso P, Keller EA, Salica C and Orsingher OA (1983) Vascular reactivity in
perinatally undernourished rats. Eur J Pharmacol 87:107-111.
Guyton AC, Polizo D and Armstrong GG (1954) Mean circulatory filling pressure
measured immediately after cessation of heart pumping. Am J Physiol 179:261-267.
Handy DE, Flordellis CS, Bogdanova NN, Bresnahan MR and Gavras H (1993) Diverse
tissue expression of rat alpha 2-adrenergic receptor genes. Hypertension 21:861-865.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
22
Henze M, Osei-Owusu P and Scrogin KE. The baroreflex mediates the dis-ihibition of
sympathetic drive in response to prolonged hemorrhage. FASEB J 19, A614. 2005.
Ito H and Hirakawa S (1984) Effects of vasodilators on the systemic capacitance vessels,
a study with the measurement of the mean circulatory pressure in dogs. Jpn Circ J
48:388-404.
Kam PC, Williams S and Yoong FF (2004) Vasopressin and terlipressin: pharmacology
and its clinical relevance. Anaesthesia 59:993-1001.
Kaufman S and Deng Y (1993) Splenic control of intravascular volume in the rat. J
Physiol 468:557-565.
Kuwahira I, Kamiya U, Iwamoto T, Moue Y, Urano T, Ohta Y and Gonzalez NC (1999)
Splenic contraction-induced reversible increase in hemoglobin concentration in
intermittent hypoxia. J Appl Physiol 86:181-187.
Meier-Hellmann A, Reinhart K, Bredle DL, Specht M, Spies CD and Hannemann L
(1997) Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 25:399-
404.
Oberg B and Thoren P (1970) Increased activity in vagal cardiac afferents correlated to
the appearance of reflex bradycardia during severe hemorrhage in cats. Acta Physiol
Scand 80:22A-23A.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
23
Osei-Owusu P and Scrogin KE. 5-HT1A Receptor activation attenuates reperfusion
injury after prolonged hypovolemia. The FASEB Journal 18(5), A1244. 2004a.
Osei-Owusu P and Scrogin KE (2004b) Buspirone raises blood pressure through
activation of sympathetic nervous system and by direct activation of alpha1-adrenergic
receptors after severe hemorrhage. J Pharmacol Exp Ther 309:1132-1140.
Pang CC (2001) Autonomic control of the venous system in health and disease: effects of
drugs. Pharmacol Ther 90:179-230.
Pang CC and Tabrizchi R (1986) The effects of noradrenaline, B-HT 920, methoxamine,
angiotensin II and vasopressin on mean circulatory filling pressure in conscious rats. Br J
Pharmacol 89:389-394.
Rowe BP, Noble AR and Munday KA (1979) Blockade of pressor responses to
angiotensins I and II and noradrenaline using phentolamine, propranolol and
hexamethonium in conscious rabbits. Pflugers Arch 382:269-274.
Schadt JC and Ludbrook J (1991) Hemodynamic and neurohumoral responses to acute
hypovolemia in conscious mammals. Am J Physiol 260:H305-H318.
Scrogin KE (2003) 5-HT1A receptor agonist 8-OH-DPAT acts in the hindbrain to reverse
the sympatholytic response to severe hemorrhage. Am J Physiol Regul Integr Comp
Physiol 284:R782-R791.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
24
Seki K, Aibiki M and Ogura S (1997) 3.5% hypertonic saline produces sympathetic
activation in hemorrhaged rabbits. J Auton Nerv Syst 64:49-56.
Semkova I, Wolz P and Krieglstein J (1998) Neuroprotective effect of 5-HT1A receptor
agonist, Bay X 3702, demonstrated in vitro and in vivo. Eur J Pharmacol 359:251-260.
Shiah IS, Yatham LN, Lam RW, Tam EM and Zis AP (1998) Cortisol, hypothermic, and
behavioral responses to ipsapirone in patients with bipolar depression and normal
controls. Neuropsychobiology 38:6-12.
Van Lieshout JJ, Wieling W, Karemaker JM and Secher NH (2003) Syncope, cerebral
perfusion, and oxygenation. J Appl Physiol 94:833-848.
Warner TD (1990) Simultaneous perfusion of rat isolated superior mesenteric arterial and
venous beds: comparison of their vasoconstrictor and vasodilator responses to agonists.
Br J Pharmacol 99:427-433.
Yamamoto J, Trippodo NC, Ishise S and Frohlich ED (1980) Total vascular pressure-
volume relationship in the conscious rat. Am J Physiol 238:H823-H828.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
25
Footnotes
This study was supported by grants from the National Institutes of Health RO1
HL072354 and RO1 HL076162 to Dr. K. Scrogin.
Reprint requests should be sent to:
Karie Scrogin, Ph.D, Department of Pharmacology, Loyola University Chicago, Stritch
School of Medicine, 2160 S. First Ave., Maywood, IL 60153
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
26
Legends for Figures
Figure 1. Mean arterial pressure (MAP), heart rate (HR) and central venous pressure
(CVP) during hemorrhage (duration indicated by shaded box) and subsequent injection of
8-OH-DPAT, saline or epinephrine infusion. Data are groups means ± S.E. Data prior to
drug injection are pooled. Group n’s indicated in parentheses. **P<0.01 8-O-DPAT vs.
saline, ††P<0.01 Epinephrine vs. saline, §P<0.05 Epinephrine vs. 8-OH-DPAT. All
groups were given saline pre-treatment as a control for other pretreatments used in
subsequent studies.
Figure 2. Mean circulatory filling pressure (MCFP) 10 min prior to hemorrhage and 20,
30, 40 ,50 and 60 min after start of blood withdrawal (shaded box) in animals treated with
saline, 8-OH-DPAT or epinephrine. Data are group means ± S.E. Group n’s are in
parentheses. **P<0.01 vs. saline, +P<0.05 vs. epinephrine.
Figure 3. Mean arterial pressure (MAP) during hemorrhage (shaded box) and subsequent
administration of hexamethonium chloride (Hex) or saline (15 min), followed by either 8-
OH-DPAT or saline (25 min). Data are pooled prior to first injection, then divided into
Hex- (closed triangles) and saline-treated (closed circles) groups following the first
injection and further divided into the 4 final groups following the second injection.
Shading delineates pressor response to 8-OH-DPAT with respect to its appropriate
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
27
control group in intact (light gray) and ganglionic blocked (dark gray) animals. Darkest
shading indicates overlap between pressor responses. Intact 8-OH-DPAT- and saline-
treated group data taken from experiment 1 are included in analysis. Data are groups
means ± S.E. Groups n’s are in parentheses. **P<0.01 Saline + 8-OH-DPAT vs. Saline
+ Saline, §§P<0.01 Saline + 8-OH-DPAT vs. Hex + 8-OH-DPAT, #,##P<0.05, 0.01 Hex +
8-OH-DPAT vs. Hex + Saline, ++P<0.01 Hex + Saline vs. Saline + Saline.
Figure 4. Mean circulatory filling pressure (MCFP) prior to hemorrhage and 20, 30 ,40,
50 and 60 min after start of blood withdrawal in animals given saline or 8-OH-DPAT
following ganglionic blockade with hexamethonium chloride. Data are group means ±
S.E. Group n’s indicated in parentheses of legend.
Figure 5. Mean arterial pressure (MAP) during hemorrhage and subsequent
administration of prazosin (Prz) or saline (15 min), followed by either 8-OH-DPAT or
saline (25 min). Data are pooled prior to first injection, then divided into prazosin-
(closed triangles) and saline-treated (closed circles) groups following the first injection
and further divided into the 4 final groups following the second injection. Shading
represents pressor response to 8-OH-DPAT with respect to its appropriate control group
in intact (light gray) and prazosin pre-treated (dark gray) animals. The intact 8-OH-
DPAT- and saline-treated group data are included from experiment 1. Data are group
means ± S.E. Group n’s indicated in parentheses. **P<0.01 Saline + 8-OH-DPAT vs.
Saline + Saline, §§P<0.05 Saline + 8-OH-DPAT vs. Prz + 8-OH-DPAT, +,++P<0.05, 0.01
Prz + Saline vs. Saline + Saline.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
28
Figure 6. Mean circulatory filling pressure (MCFP) prior to hemorrhage and 20, 30 ,40,
50 and 60 min after start of blood withdrawal in animals given saline or 8-OH-DPAT
following prazosin. Data are group means ± S.E. Group n’s provided in parentheses in
legend.
Figure 7. Mean arterial pressure (MAP) during hemorrhage and subsequent
administration of the α2-adrenergic receptor antagonist, L-659,066, or saline (15 min),
followed by either 8-OH-DPAT or saline (25 min). Data are pooled prior to first
injection, then divided into L-659,066 (closed triangles) and saline-treated (closed
circles) groups following the first injection, then divided further into the 4 final groups
following the second injection. Shading represents pressor response to 8-OH-DPAT with
respect to its appropriate control group in intact (light gray) and L-659,066-treated (dark
gray) animals. Darkest gray indicates overlap between pressor responses. The intact 8-
OH-DPAT- and saline-treated group data are included from experiment 1. Data are
group means ± S.E. ‡,‡‡ P<0.05, 0.01, L-659,066 vs. saline (prior to second injection).
**P<0.01 Saline + 8-OH-DPAT vs. Saline + Saline, +,++P<0.05, 0.01 L-659,066 + Saline
vs. Saline + Saline. There was no interaction between 8-OH-DPAT and L-659,066
treatment so differences are not reported
Figure 8. Mean circulatory filling pressure (MCFP) prior to hemorrhage and 20, 30 ,40,
50 and 60 min after start of blood withdrawal in animals given saline or 8-OH-DPAT
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
29
following L-659,066. Data are group means ± S.E. Group n’s provided in parentheses in
legend.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
JPET #108944
30
Table 1. Blood Volume Parameters
Total blood loss (ml/kg)
∆ Hematocrit (%)
∆ Plasma protein (g/100 ml)
Saline + Saline (10) -3.9±0.9 -0.57±0.10
Saline + 8-OH-DPAT (10) -3.6±0.9 -0.47±0.10
Epinephrine (8)
35.0 ± 0.10
-6.3±1.2 -0.61±0.06
Hex + Saline (8) -5.5±0.5 -0.63±0.07
Hex + 8-OH-DPAT (8) 29.6 ± 0.10**††
-5.9±0.7 -0.60±0.06
Prazosin + Saline (8) -6.3±1.0 -0.56±0.10
Prazosin + 8-OH-DPAT (9) 25.9 ± 0.10**††
-4.4±0.7 -0.43±0.13
L-659,066 + Saline (7) -1.0±1.8 +0.17±0.37
L-659,066 + 8-OH-DPAT (7) 34.3 ± 0.04
-1.0±1.7 -0.04±0.31
Values are mean ± S.E. Blood loss data are pooled across pre-treatment
groups. Hematocrit and plasma protein determined 10 min after initiation of
blood withdrawal and end of recovery, 60 min after start of hemorrhage.
**P<0.01 vs. saline pre-treatment, ††P<0.01 vs. L-659,066 pre-treatment.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on August 2, 2006 as DOI: 10.1124/jpet.106.108944
at ASPE
T Journals on A
pril 6, 2020jpet.aspetjournals.org
Dow
nloaded from